Insulet Corp: Form 10-K for the period ended Dec 31, 2014
Filed with the SEC on Feb 26, 2015 and accepted by EDGAR at Feb 26, 2015, 21:43 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-10-01 to 2014-12-31 | $72.6m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $145.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2014-10-01 to 2014-12-31 | $36.7m | us-gaap:GrossProfit |
| Gross profit | 12 months2014-01-01 to 2014-12-31 | $143.3m | us-gaap:GrossProfit |
| Research and development | 12 months2014-01-01 to 2014-12-31 | $27.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2014-01-01 to 2014-12-31 | −$12.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2014-01-01 to 2014-12-31 | $142.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-10-01 to 2014-12-31 | −$5.4m | us-gaap:NetIncomeLoss |
| Net income | 12 months2014-01-01 to 2014-12-31 | −$51.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-01 to 2014-12-31 | −$0.10 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | −$0.93 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | $8.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2014-01-01 to 2014-12-31 | $11.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-12-31 | $151.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $208.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $302.2m | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $44.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-31 | $218.3m | us-gaap:Liabilities |
| Long-term debt | At period end2014-12-31 | $169.0m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2014-12-31 | $83.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-15-000020. Last ingested by Listed: Nov 14, 2026, 12:01 ET. Listed shows no prices and gives no investment advice.